SBI-993 structure
|
Common Name | SBI-993 | ||
---|---|---|---|---|
CAS Number | 2073059-82-0 | Molecular Weight | 452.529 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C23H24N4O4S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of SBI-993SBI-993 is an analog of SBI-477 that shows improved potency and suitable pharmacokinetic properties for in vivo bioavailability; reduces Txnip and Arrdc4 expression to a degree similar to that seen with SBI-477 in human myotubes; reduces muscle and liver TAG levels, enhances insulin signaling, and improved glucose tolerance in mice fed a high-fat diet. |
Name | SBI-993 |
---|
Description | SBI-993 is an analog of SBI-477 that shows improved potency and suitable pharmacokinetic properties for in vivo bioavailability; reduces Txnip and Arrdc4 expression to a degree similar to that seen with SBI-477 in human myotubes; reduces muscle and liver TAG levels, enhances insulin signaling, and improved glucose tolerance in mice fed a high-fat diet. |
---|---|
References | References 1. Ahn B, et al. J Clin Invest. 2016 Sep 1;126(9):3567-79. View Related Products by Target Other Targets |
Molecular Formula | C23H24N4O4S |
---|---|
Molecular Weight | 452.529 |